Publication

Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal"

Ramaekers, B. L. T., Riemsma, R., Tomini, F., van Asselt, T., Deshpande, S., Duffy, S., Armstrong, N., Severens, J. L., Kleijnen, J. & Joore, M. A., Jun-2017, In : Pharmacoeconomics. 35, 6, p. 665-667 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Copy link to clipboard

Documents

  • Response to Letter to the Editor Regarding “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer

    Final publisher's version, 409 KB, PDF document

DOI

  • Bram L. T. Ramaekers
  • Rob Riemsma
  • Florian Tomini
  • Thea van Asselt
  • Sohan Deshpande
  • Steven Duffy
  • Nigel Armstrong
  • Johan L. Severens
  • Jos Kleijnen
  • Manuela A. Joore
Original languageEnglish
Pages (from-to)665-667
Number of pages3
JournalPharmacoeconomics
Volume35
Issue number6
Publication statusPublished - Jun-2017

ID: 42528112